ISOLATED TERATOZOOSPERMIA: IS THERE A ROLE FOR ANTIOXIDANT THERAPY?


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

Recently, literature has emerged that offers contradictory findings of idiopathic forms of isolated teratozoospermia that may confuse clinicians. Some researchers argue that at 0-1% of normal forms of spermatozoa, morphology itself cannot be a prognostic indicator of fertility, either in the planning of natural pregnancy, or when used in assisted reproduction. In this connection, the possible causes of teratozoospermia and alternative therapies are being actively sought, in addition to known invasive and costly procedures. There is convincing evidence that reactive oxygen species overproduction is associated with the occurrence of abnormal spermatozoa in the ejaculate. An abnormal morphology can be accompanied by damage to the sperm DNA, impaired chromatin condensation, and associated unsuccessful pregnancy outcomes. Most of the studies show that using antioxidants results in positive changes. This literature review highlights the role of oxidative stress and DNA fragmentation in the formation of morphologically abnormal spermatozoa. The authors discuss drug interventions to treat teratozoospermia and present their own recommendations for antioxidant therapy in the clinical management of idiopathic forms of male infertility.

Толық мәтін

Рұқсат жабық

Авторлар туралы

E. Efremov

N.A. Lopatkin Scientific Research Institute of Urology and Interventional Radiology - branch of NMRRC of Minzdrav of Russia

Dr.Med.Sci. Head of the Department of Andrology and Human Reproduction Moscow, Russia

E. Kasatonova

N.A. Lopatkin Scientific Research Institute of Urology and Interventional Radiology - branch of NMRRC of Minzdrav of Russia

Email: kasatonova@yandex.ru
Researcher at the Department of Andrology and Human Reproduction Moscow, Russia

Ya. Mel’nik

N.A. Lopatkin Scientific Research Institute of Urology and Interventional Radiology - branch of NMRRC of Minzdrav of Russia

Researcher at the Department ofAndrology and Human Reproduction Moscow, Russia

A. Nikushina

N.A. Lopatkin Scientific Research Institute of Urology and Interventional Radiology - branch of NMRRC of Minzdrav of Russia

Researcher at the Research and Methodology Department of Andrology and Human Reproduction Moscow, Russia

Әдебиет тізімі

  1. Cooper T.G., Noonan E., et al. World Health Organization reference values for human semen characteristics. Hum Reprod Update. 2010 May-Jun;16(3):231- 245. doi: 10.1093/humupd/dmp048.
  2. American Urological Association Education and Research, Inc. (2011) The optimal evaluation ofthe infertile male: AUA best practice statement. Linthicum (MD): American Urological Association Education and Research, Inc. http:// www.auanet.org/guidelines/male-infertility-optimal-evaluation-(reviewed-and-validity-confirmed-2011). Доступ от 21 сентября 2017 г.
  3. Kruger T.F., Menkveld R., et al. Sperm morphologic features as a prognostic factor in in vitro fertilization. Fertil Steril. 1986;46:1118-1123.
  4. WHO. (2010) WHO Laboratory Manual for the Examination of Human Semen and Sperm-cervical Mucus and Interaction. World Health Organisation. http://apps.who.int/iris/bitstream/10665/44261/34/97859051060905_rus.pdf Обращение от 10.09.2017.
  5. Gatimel N., Moreau J., et al. Sperm morphology: assessment, pathophysiology, clinical relevance, and state of the art in 2017. Andrology. 2017;5(5):845-862. doi: 10.1111/andr.12389.
  6. Menkveld R. Clinical significance of the low normal sperm morphology value as proposed in the fifth edition of the WHO Laboratory Manual for the Examination and Processing of Human Semen. Asian J Androl. 2010;12(1):47-58. doi: 10.1038/aja.2009.14.
  7. Auger J., Eustache F., et al. Sperm morphological defects related to environment, lifestyle and medical history of 1001 male partners of pregnant women from four European cities. Hum Reprod. 2001;16(12):2710-2717.
  8. Menkveld R., Holleboom C.A., Rhemrev J.P. Measurement and significance of sperm morphology. Asian Journal of Andrology. 2011 ;13(1):59-68. doi: 10.1038/aja.2010.67.
  9. Carlsen E., Giwercman A., et al. Evidence for decreasing quality of semen during past 50 years. BMJ : British Medical Journal. 1992;305(6854):609-613.
  10. Benshushan A., Shoshani O., et al. Is there really a decrease in sperm parameters among healthy young men? A survey of sperm donations during 15 years. J Assist Reprod Genet. 1997;14:347-353.
  11. Chen Z., Isaacson K.B., et al. Temporal trends in human semen parameters in New England in the United Stated, 1989-2000. Arch Androl. 2003;49:369-74.
  12. Morbeck D.E., Leonard P.H., et al. Sperm morphology: classification drift over time and clinical implications. Fertil Steril. 2011;96(6):1350-1354. doi: 10.1016/j.fertnstert.2011.08.036.
  13. Akashi T., Watanabe A., et al. Evaluation of the sperm motility analyzer system (SMAS) for the assessment of sperm quality in infertile men. Syst Biol Reprod Med. 2010;56(6):473-437. doi: 10.3109/19396361003786293.
  14. Mortimer S.T., van der Horst G., Mortimer D. The future ofcomputer-aided sperm analysis. Asian Journal of Andrology. 2015;17(4):545-553. doi: 10.4103/1008-682X.154312.
  15. Swan S.H., Elkin E.P., Fenster L. The question of declining sperm density revisited: an analysis of studies published 1934-1996. Environ Health Perspect. 2000;108:961-966.
  16. Shcheplev P. A., Apolikhin O. I. Male infertility. Discussion of the consensus. Vestnik reproduktsii. 2010;3-4:37-44. Russian (Щеплев ПА., Аполихин О.И. Мужское бесплодие. Обсуждение консенсуса. Вестник репродукции. 2010;3-4:37-44).
  17. Kovac J.R., Smith R.P., et al. Men with a complete absence of normal sperm morphology exhibit high rates of success without assisted reproduction. Asian Journal of Andrology. 2017;19(1):39-42. doi: 10.4103/1008-682X.189211.
  18. Lee R.K., Hou J.W., Ho H.Y., et al. Sperm morphology analysis using strict criteria as a prognostic factor in intrauterine insemination. Int J Androl. 2002 Oct;25(5):277-280.
  19. Spiessens C., Vanderschueren D., et al. T. Isolated teratozoospermia and intrauterine insemination. Fertil Steril. 2003;80(5):1185-1189.
  20. Van Waart J., Kruger T.F., et al. Predictive value of normal sperm morphology in intrauterine insemination (IUI): a structured literature review. Hum Reprod Update. 2001;7(5):495-500.
  21. Shabtaie S.A., Gerkowicz S.A., et al. Role of Abnormal Sperm Morphology in Predicting Pregnancy Outcomes. Curr Urol Rep. 2016;17(9):67. Doi: 10.1007/ s11934-016-0623-1.
  22. Sun Y., Li B., et al. Does sperm morphology affect the outcome of intrauterine insemination in patients with normal sperm concentration and motility? Andrologia. 2012;44(5):299-304. doi: 10.1111/j.1439-0272.2012.01280.x.
  23. Lemmens L., Kos S., et al. Semen Section of the Dutch Foundation for Quality Assessment in Medical Laboratories. Predictive value of sperm morphology and progressively motile sperm count for pregnancy outcomes in intrauterine insemination. Fertil Steril. 2016;105(6):1462-1468. Doi: 10.1016/j. fertnstert.2016.02.012.
  24. Hotaling J.M., Smith J.F., et al. The relationship between isolated teratozoospermia and clinical pregnancy after in vitro fertilization with or without intracytoplasmic sperm injection: a systematic review and meta-analysis. Fertil Steril. 2011;95(3):1141-1145. doi: 10.1016/j.fertnstert.2010.09.029.
  25. French D.B., Sabanegh E.S. Jr, et al. Does severe teratozoospermia affect blastocyst formation, live birth rate, and other clinical outcome parameters in ICSI cycles? Fertil Steril. 2010;93(4):1097-1103. Doi: 10.1016/j. fertnstert.2008.10.051.
  26. Pereira N., Neri Q.V., et al. Outcomes ofIntracytoplasmic Sperm Injection Cycles for Complete Teratozoospermia: A Case-Control Study Using Paired Sibling Oocytes. Biomed Res Int. 2015;2015:470819. doi: 10.1155/2015/470819.
  27. He B., Cheng J.P., et al. [Normal sperm morphology and the outcomes of routine in vitro fertilization]. Zhonghua Nan Ke Xue. 2016;22(1):32-36. Abstract.
  28. Брагина Е.Е., Сорокина Т.М., и др. Генетически обусловленные формы патозооспермии. Обзор литературы и результаты исследований. Андрология и генитальная хирургия. 2015;16(3):29-39. doi: 10.17650/2070-9781-2015-16-3-29-39
  29. Kihaile P., Hirotsuru K., et al. Fertilization rrates of small-headed sperm in conventional IVF and ICSI. Arch Androl. 2003;49:327-329.
  30. Yeung C.H., Tüttelmann F., et al. Coiled sperm from infertile patients: characteristics, associated factors and biological implication. Hum Reprod. 2009;24(6):1288-1295. doi: 10.1093/humrep/dep017.
  31. Buck Louis G.M., Sundaram R., et al. Semen quality and time to pregnancy: the Longitudinal Investigation of Fertility and the Environment Study. Fertil Steril. 2014;101(2):453-62. doi: 10.1016/j.fertnstert.2013.10.022.
  32. Nikfar S., Rahimi R., et al. A meta-analysis of the efficacy of sulfasalazine in comparison with 5-aminosalicylates in the induction of improvement and maintenance of remission in patients with ulcerative colitis. Dig Dis Sci. 2009;54(6):1157-1170. doi: 10.1007/s10620-008-0481-x.
  33. Sun F., Ko E., Martin R.H. Is there a relationship between sperm chromosome abnormalities and sperm morphology? Reproductive Biology and Endocrinology. 2006;4:1. doi: 10.1186/1477-7827-4-1.
  34. Moskovtsev S.I., Lecker I., et al. Cause-specific treatment in patients with high sperm DNA damage resulted in significant DNA improvement. Syst Biol Reprod Med. 2009;55(2):109-115. doi: 10.1080/19396360902787944.
  35. Machev N., Gosset P., Viville S. Chromosome abnormalities in sperm from infertile men with normal somatic karyotypes: teratozoospermia. Cytogenet Genome Res. 2005;111(3-4):352-357. doi: 10.1159/000086910.
  36. Auger J., Jouannet P., Eustache F. Another look at human sperm morphology. Hum Reprod. 2016;31(1):10-23. doi: 10.1093/humrep/dev251.
  37. Prasivoravong J., Marcelli F., et al. Beneficial effects of varicocele embolization on semen parameters. Basic Clin Androl. 2014;24:9. doi: 10.1186/2051-4190-24-9. eCollection 2014.
  38. Rengan A.K., Agarwal A., et al. An investigation of excess residual cytoplasm in human spermatozoa and its distinction from the cytoplasmic droplet. Reprod Biol Endocrinol 2012;10:92. doi: 10.1186/1477-7827-10-92
  39. Aziz N., Saleh RA., et al. Novel association between sperm reactive oxygen species production, sperm morphological defects, and the sperm deformity index. Fertil Steril. 2004;81:349-354. doi: 10.1016/j.fertnstert.2003.06.026.
  40. Patel C.J., Sundaram R., Buck Louis G.M. A data-driven search for semen-related phenotypes in conception delay. Andrology. 2017;5(1):95-102. doi: 10.1111/andr.12288.
  41. Coutton C., Escoffier J., et al. Teratozoospermia: spotlight on the main genetic actors in the human. Hum Reprod Update. 2015;21(4):455-485. Doi: 10.1093/ humupd/dmv020.
  42. Gavriliouk D., Aitken R.J. Damage to Sperm DNA Mediated by Reactive Oxygen Species: Its Impact on Human Reproduction and the Health Trajectory of Offspring. Adv Exp Med Biol. 2015;868:23-47.
  43. Agarwal A., Tvrda E., Sharma R. Relationship amongst teratozoospermia, seminal oxidative stress and male infertility. Reproductive Biology and Endocrinology : RB&E. 2014;12:45. doi: 10.1186/1477-7827-12-45.
  44. Varshini J., Srinag B.S., et al. Poor sperm quality and advancing age are associated with increased sperm DNA damage in infertile men. Andrologia. 2012;44:642-649. doi: 10.1111/j.1439-0272.2011.01243.x.
  45. Avendano C., Franchi A., et al. Fragmentation of DNA in morphologically normal human spermatozoa. Fertil Steril. 2009;91:1077-1084. Doi: 10.1016/j. fertnstert.2008.01.015.
  46. Oliveira J.B., Massaro F.C., et al. Correlation between semen analysis by motile sperm organelle morphology examination and sperm DNA damage. Fertil Steril. 2010;94:1937-1940. doi: 10.1016/j.fertnstert.2010.01.042.
  47. Руднева С.А., Брагина Е.Е., и др. Фрагментация ДНК в сперматозоидах и ее взаимосвязь с нарушением сперматогенеза. Андрология и генитальная хирургия. 2014;15(4):26-33. doi: 10.17650/2070-9781-2014-4-26-33
  48. Hamada A.J., Montgomery B., Agarwal A. Male infertility: a critical review of pharmacologic management. Expert Opin Pharmacother. 2012;13(17):2511- 2531. doi: 10.1517/14656566.2012.740011.
  49. Safarinejad M.R., Safarinejad S., et al. Effects of the reduced form of coenzyme Q10 (ubiquinol) on semen parameters in men with idiopathic infertility: a double-blind, placebo controlled, randomized study. J Urol. 2012;188(2):526- 531. doi: 10.1016/j.juro.2012.03.131.
  50. Nadjarzadeh A., Shidfar F., et al. Effect of Coenzyme Q10 supplementation on antioxidant enzymes activity and oxidative stress of seminal plasma: a doubleblind randomised clinical trial. Andrologia. 2014;46(2):177-183. Doi: 10.1111/ and.12062.
  51. Haseen Ahmed S.D., et al. Relationship of seminal free L-Carnitine with functional spermatozoal characteristics: Results from an observational study conducted in a tertiary care hospital of Karachi, Pakistan. J Pak Med Assoc. 2017;67(2):280-284.
  52. Zhao J., Dong X. et al. Zinc levels in seminal plasma and their correlation with male infertility: A systematic review and meta-analysis. Scientific Reports. 2016;6:22386. doi: 10.1038/srep22386.
  53. Moslemi M.K., Tavanbakhsh S. Selenium-vitamin E supplementation in infertile men: effects on semen parameters and pregnancy rate. Int J Gen Med. 2011;4:99-104. doi: 10.2147/IJGM.S16275.
  54. Abd-Elrazek A.M., Ahmed-Farid O.A.H. Protective effect of L-carnitine and L-arginine against busulfan-induced oligospermia in adult rat. Andrologia. 2017 Apr 25. doi: 10.1111/and.12806.
  55. Камалов АА., Абоян ИА, и др. Применение биологически активного комплекса Андродоз® у пациентов с патоспермией и иммунологическим фактором инфертильности. Результаты мультицентрового клинического исследования. Фарматека. 2014;4 (277):32-44
  56. Дендеберов Е.С., Виноградов И.В. Опыт применения биокомплекса АндроДоз для фертилизации больных с идиопатической патоспермией. Эффективная фармакотерапия. Урология и нефрология. 2014;4(41):24-26
  57. Цуканов А.Ю., Делицин А.С. Влияние андродоза на качество семенной плазмы. Андрология и генитальная хирургия. 2017;18(1):99-101. doi: 10.17650/2070-9781-2017-18-1-99-101
  58. Zini A., San Gabriel M., Baazeem A. Antioxidants and sperm DNA damage: a clinical perspective. J Assist Reprod Genet 2009;26(8):427-432. Doi: 10.1007/ s10815-009-9343-5.
  59. Aitken R.J., Paterson M., et al. Redox regulation of tyrosine phosphorylation in human spermatozoa and its role in the control of human sperm function. J Cell Sci 1995;108(Pt 5):2017-2025.
  60. Khaki A., Novin M.G., et al. Comparative study of the effects of gentamicin, neomycin, streptomycin and ofloxacin antibiotics on sperm parameters and testis apoptosis in rats. Pak J Biol Sci. 2008;11(13):1683-1639.
  61. Yadav S.B., Suryakar A.N., et al. Effect of antioxidants and antibiotics on levels of seminal oxidative stress in leukocytospermic infertile men. Indian J Clin Biochem. 2006;21(1):152-156.
  62. Azadi L., Abbasi H., et al. Zaditen (Ketotifen), as mast cell blocker, improves sperm quality, chromatin integrity and pregnancy rate after varicocelectomy. Int J Androl 2010;t34(5 Pt 1):446-452. doi: 10.1111/j.1365-2605.2010.01112.x
  63. Ramasamy R., Stahl P.J., Schlegel P.N. Medical therapy for spermatogenic failure. Asian Journal ofAndrology. 2012;14(1):57-60.
  64. Tang W.H., Jiang H., et al. [Relationship ofsperm morphology with reproductive hormone levels in infertile men]. Zhonghua Nan Ke Xue. 2012;18(3):243-247.
  65. Baccetti B., Strehler E., et al. The effect of follicle stimulating hormone therapy on human sperm structure (Notulae seminologicae 11). Hum Reprod 1997;12:1955-1968.
  66. ElSheikh M.G., Hosny M.B., et al. Combination of vitamin E and clomiphene citrate in treating patients with idiopathic oligoasthenozoospermia: A prospective, randomized trial. Andrology. 2015;3(5):864-867.
  67. Bozhedomov V.A., Lipatova N.A., et al. Using L- and acetyl-L-carnintines in combination with clomiphene citrate and antioxidant complex for treating idiopathic male infertility: a prospective randomized trial. Urologiia. 2017;(3):22-32.
  68. Dimitriadis F., Tsambalas S., et al. Effects of phosphodiesterase-5 inhibitors on Leydig cell secretory function in oligoasthenospermic infertile men: a randomized trial. BJU Int. 2010;106(8):1181-1185. doi: 10.1111/j.1464-410X.2010.09243.x.
  69. Ефремов Е.А., Ефремов Г.Д.и др. Влияние ингибиторов фосфодиэстеразы 5-го типа на сперматогенез в эксперименте на крысах. Медицинский вестник Башкортостана. 2013;2:55-58
  70. Okada H., Tatsumi N., et al. Formation of reactive oxygen speciesby spermatozoa from asthenospermic patients: response to treatment with pentoxifylline. J Urol 1997;57(6):2140-2146
  71. Камалов АА., Божедомов В.А., Вартанян Э.В. и др. Андрология. Фармакология без ошибок / под ред. акад. РАН Камалова А.А Руководство для врачей. Е-ното Подольск, 2017. С. 384
  72. Камалов А.А., Ефремов Е.А., Охоботов Д.А. Лекарственная терапия мужского бесплодия. Новая аптека. 2007;3:28-32
  73. Дорофеев С.Д., Ефремов Е.А., Симаков В.В. Терапия идиопатической патоспермии. Эффективная фармакотерапия. Урология и Нефрология. 2015;2
  74. Адаптированная версия. Схема разработана в 2007 г. Ефремовым Е.А и Охоботовым Д.А для доклада «Лекарственная терапия мужского бесплодия» на Х Конгрессе Российского общества урологов
  75. Ефремов Е.А., Касатонова Е.В., Мельник Я.И. и др. К вопросу о мужском вкладе в невынашивание беременности и нарушения раннего эмбриогенеза. Эффективная фармакотерапия. Урология и Нефрология. 2016;4 (33):18-31
  76. Ефремов ЕА., Касатонова Е.В., Мельник Я.И. и др. Антиоксидантная терапия мужского бесплодия как возможность улучшить исходы вспомогательных репродуктивных технологий. Эффективная фармакотерапия. Урология и Нефрология. 2017;4(22):32-43

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML

© Bionika Media, 2017

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>